Get in touch

Tiefenbacher Group and Neuraxpharm announce the launch of Riulvy ® (Tegomil Fumarate) in Germany

Tiefenbacher Group Neuraxpharm Riulvy Germany

Tiefenbacher Group and Neuraxpharm announce the launch of Riulvy® (Tegomil Fumarate) in GermanyAt Tiefenbacher Group, we are deeply committed to developing and delivering high-quality, value-added pharmaceuticals that improve the lives of patients worldwide. In collaboration with our trusted partner Neuraxpharm we are proud to announce the successful launch of Riulvy ® (Tegomil Fumarate) 174 mg […]

Tiefenbacher New Market Launch: Buprenorphine Patches in South Africa

Tiefenbacher Group - A smiling older man with a gray beard sits while a woman stands behind him, hugging him. Text reads, "LAUNCH OF BUPRENORPHINE IN SOUTH AFRICA." The TIEFENBACHER PHARMACEUTICALS logo is at the top, highlighting expertise in generic medicines manufacturing.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in South Africa. We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. That’s why we are thrilled to share that we have successfully prepared the launch of the generic version […]

Pioneering Healthcare at Tiefenbacher Group

Tiefenbacher Group - A man in a light blue shirt sits and gestures while speaking in a bright office. A quote by Dr. Kristian Ruepp highlights curiosity, excellence, and patient-centric drug development in pharmaceutical healthcare solutions.

At Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering healthcare. Our core values of being CURIOSITY DRIVEN, EXCELLENCE FOCUSED, and PATIENT CENTERED guide our actions and decisions every day. These values help us achieve our purpose of making high-quality pharmaceuticals more […]

Tiefenbacher Group about affordable medicines

Tiefenbacher Group - A pharmacist in a white coat smiles behind a counter. Infographics display bar charts on the European affordable medicines market, highlighting economic value, supply chain, access, and innovation by a family-owned pharmaceutical company.

Why are affordable medicines so important for healthcare?Did you know that affordable (generic) medicines represent the majority of treatments in Europe, accounting for 70% of the treatment volume and 19% of the market value in 2023? They play a crucial role in ensuring patient well-being and public health by providing safe, effective, and affordable treatments. […]

Get in touch